Bioanalytical Testing Services Market Analysis By Molecule-Type (Small Molecule, Large Molecule), By Test Type (ADME, PK, PD, Bioavailability, Bioequivalence), By Region, And Segment Forecasts, 2014 - 2025

  • ID: 4330277
  • Report
  • 114 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Covance, Inc
  • ICON plc
  • Intertek Group plc
  • inVentiv Health
  • SGS SA
  • Toxikon, Inc
  • MORE
The global bioanalytical testing services market is anticipated to reach USD 3.0 billion by 2025. The performance of market players in bioanalytical testing domain is highly influenced by the level of demand from end-user side. Due to intense market efforts, increasing awareness level, improving accessibility, and government initiatives, consumers, these days, are more concerned about self-care, resulting in higher consumption of pharmaceutical products.

There is a major price difference observed between conducting analytical tests in-house and outsourcing. A company may lack the required set-up and expertise to perform every possible test in-house. In addition, there are serval no routine activities that are needed to be performed only once. These include registration stability storage & testing, process & facility validation work, cleaning validations, analytical testing using expensive equipment & method development.

The bioanalytical testing services market based on molecule type is bifurcated into small molecule testing and large molecule testing. Small molecule bioanalytical testing held a lucrative share in 2016. Most of the generic and branded drug compounds are of small molecule category. Additionally, with the patent expiration many blockbuster drugs, generic manufacturers are required to conduct and submit bioanalytical testing results. These factors primarily governed the growth of the small molecule drug bioanalytical testing market. On the contrary, large molecule bioanalytical testing services are anticipated to exhibit healthy growth over the forecast period. This can be attributed to a rich pipeline of biologics or amino acid based products.

Further Key Findings From the Study Suggest:
  • Large molecule bioanalytical testing services are anticipated to exhibit healthy growth over the forecast period. This can be attributed to a rich pipeline of biologics or amino acid based products
  • LC-MS studies are vital in bioanalysis of large molecules. They can be used for various methods such as development & validation, preclinical & clinical sample analysis, immunoanalytical solutions, and microfluidic tests for biologics
  • In vivo ADME is designed to assess biopharmaceutical characteristic of a drug at preclinical level. Service providers offer customized study on variety of species. QWBA, mass balance, excretion, expired air collection in rodents, metabolite profiling, and radioactivity sample analysis are the key studies offered
  • North America dominated the global bioanalytical testing services market in 2016. This can be attributed to the fact that it is one of the top manufacturing hubs of highly reliable, complex, and high-end pharmaceuticals
  • Some of the key players in this market include PPD, ICON plc., Covance Inc., LabCorp, Charles River Laboratories International, Inc., inVentiv Health, SGS SA, Toxikon, Inc., Intertek group, and Pace Analytical Services, LLC.Collaborations, service portfolio expansion and merger & acquisitions are key strategic undertakings by these players
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Covance, Inc
  • ICON plc
  • Intertek Group plc
  • inVentiv Health
  • SGS SA
  • Toxikon, Inc
  • MORE
1. Methodology and Scope
1.1. Information Procurement
1.1.1. Purchased Database
1.1.2. Internal Database
1.2. Data Analysis
1.3. Market Formulation & Validation
1.4. Approaches for Market Estimation
1.4.1. Approach 1: Commodity Flow & Bottom Up Approach
1.4.2. Approach 2: Top Down and Parent Market Analysis
2. Executive Summary
2.1. Market Snapshot
3. Bioanalytical Testing Services Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.2.1. Innovation
3.2.2. Safety Regulation & Quality
3.3. Market Restraint Analysis
3.3.1. Data Insecurity
3.4. Penetration & Growth Prospect Mapping
3.5. SWOT Analysis, by Factor
3.5.1. Political
3.5.2. Economic
3.5.3. Technological
3.6. Industry Analysis - Porter’s
3.7. Company Market Share Analysis, 2016
4. Bioanalytical Testing Services: Molecule Type Estimates & Trend Analysis
4.1. Bioanalytical Testing Services Market Share, 2016 & 2025
4.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following molecule types:
4.2.1. Small Molecule
4.2.1.1. Small molecule market estimates and forecasts, 2014 to 2025
4.2.2. Large Molecule
4.2.2.1. Large molecule market estimates and forecasts, 2014 to 2025
4.2.2.2. Large molecule LC-MS studies
4.2.2.2.1. Large molecule LC-MS studies market, 2014 - 2025 (USD Million)
4.2.2.3. Immunoassay
4.2.2.3.1. Immunoassay services market, 2014 - 2025 (USD Million)
4.2.2.3.2. Pharmacokinetics(PK)
4.2.2.3.2.1. PK services market, 2014 - 2025 (USD Million)
4.2.2.3.3. Anti-Drug Antibody (ADA) services market, 2014 - 2025 (USD Million)
4.2.2.3.3.1. ADA services market, 2014 - 2025 (USD Million)
4.2.2.3.4. Other large molecule immunoassay services market, 2014 - 2025 (USD Million)
4.2.2.3.4.1. Other large molecule immunoassay services market, 2014 - 2025 (USD Million)
4.2.2.4. Others
4.2.2.4.1. Other large molecule test market, 2014 - 2025 (USD Million)
5. Bioanalytical Testing Services: Test Type Estimates & Trend Analysis
5.1. Bioanalytical Testing Services Market Share, 2016 & 2025
5.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following test-types:
5.2.1. ADME Testing
5.2.1.1. ADME testing market estimates and forecasts, 2014 to 2025
5.2.1.2. In-Vivo ADME
5.2.1.2.1. In-Vivo ADME testing market estimates and forecasts, 2014 to 2025
5.2.1.3. In-Vitro ADME
5.2.1.3.1. In-Vitro ADME testing market estimates and forecasts, 2014 to 2025
5.2.2. PK Testing
5.2.2.1. PK testing market estimates and forecasts, 2014 to 2025
5.2.3. PD Testing
5.2.3.1. PD testing market estimates and forecasts, 2014 to 2025
5.2.4. Bioavailability Testing
5.2.4.1. Bioavailability testing market estimates and forecasts, 2014 to 2025
5.2.5. Bioequivalence Testing
5.2.5.1. Bioequivalence testing market estimates and forecasts, 2014 to 2025
5.2.6. Others Testing
5.2.6.1. Others testing market estimates and forecasts, 2014 to 2025
6. Bioanalytical Testing Services: Regional Estimates & Trend Analysis
6.1. Bioanalytical Testing Services Regional Movement Analysis & Market Share, 2016 & 2025
6.2. North America
6.2.1. North America estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.2.2. North America estimates and forecasts by, test type (USD Million) 2014 - 2025
6.2.3. U.S.
6.2.3.1. U.S. estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.2.3.2. U.S. estimates and forecasts by, test type (USD Million) 2014 - 2025
6.2.4. Canada
6.2.4.1. Canada estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.2.4.2. Canada estimates and forecasts by, test type (USD Million) 2014 - 2025
6.3. Europe
6.3.1. Europe estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.3.2. Europe estimates and forecasts by, test type (USD Million) 2014 - 2025
6.3.3. UK
6.3.3.1. UK estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.3.3.2. UK estimates and forecasts by, test type (USD Million) 2014 - 2025
6.3.4. Germany
6.3.4.1. Germany estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.3.4.2. Germany estimates and forecasts by, test type (USD Million) 2014 - 2025
6.4. Asia Pacific
6.4.1. Asia Pacific estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.4.2. Asia Pacific estimates and forecasts by, test type (USD Million) 2014 - 2025
6.4.3. Japan
6.4.3.1. Japan estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.4.3.2. Japan estimates and forecasts by, test type (USD Million) 2014 - 2025
6.4.4. China
6.4.4.1. China estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.4.4.2. China estimates and forecasts by, test type (USD Million) 2014 - 2025
6.5. Latin America
6.5.1. Latin America estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.5.2. Latin America estimates and forecasts by, test type (USD Million) 2014 - 2025
6.5.3. Brazil
6.5.3.1. Brazil estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.5.3.2. Brazil estimates and forecasts by, test type (USD Million) 2014 - 2025
6.5.4. Mexico
6.5.4.1. Mexico estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.5.4.2. Mexico estimates and forecasts by, test type (USD Million) 2014 - 2025
6.6. MEA
6.6.1. MEA estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.6.2. MEA estimates and forecasts by, test type (USD Million) 2014 - 2025
6.6.3. South Africa
6.6.3.1. South Africa estimates and forecasts by, molecule type (USD Million) 2014 - 2025
6.6.3.2. South Africa estimates and forecasts by, test type (USD Million) 2014 - 2025
7. Competitive Landscape
7.1. Strategy Framework
7.2. Company Profiles
7.2.1. Pharmaceutical Product Development, LLC. (PPD)
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. ICON plc
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Covance, Inc
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Charles River Laboratories International, Inc.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Laboratory Corporation of America
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. inVentiv Health
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. SGS SA
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Toxikon, Inc
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Intertek Group plc
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Pace Analytical Services, LLC
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives

List of Tables

Table 1 North America bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 2 North America large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 3 North America large molecule immunoassay services market, by type, 2025 (USD Million)
Table 4 North America bioanalytical testing services market, by test types, 2025 (USD Million)
Table 5 North America ADME services market, by type, 2025 (USD Million)
Table 6 U.S. bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 7 U.S. large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 8 U.S. large molecule immunoassay services market, by type, 2025 (USD Million)
Table 9 U.S. bioanalytical testing services market, by test types, 2025 (USD Million)
Table 10 U.S. ADME services market, by type, 2025 (USD Million)
Table 11 Canada bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 12 Canada large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 13 Canada large molecule immunoassay services market, by type, 2025 (USD Million)
Table 14 Canada bioanalytical testing services market, by test types, 2025 (USD Million)
Table 15 Canada ADME services market, by type, 2025 (USD Million)
Table 16 Europe bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 17 Europe large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 18 Europe large molecule immunoassay services market, by type, 2025 (USD Million)
Table 19 Europe bioanalytical testing services market, by test types, 2025 (USD Million)
Table 20 Europe ADME services market, by type, 2025 (USD Million)
Table 21 UK bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 22 UK large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 23 UK large molecule immunoassay services market, by type, 2025 (USD Million)
Table 24 UK bioanalytical testing services market, by test types, 2025 (USD Million)
Table 25 UK ADME services market, by type, 2025 (USD Million)
Table 26 Germany bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 27 Germany large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 28 Germany large molecule immunoassay services market, by type, 2025 (USD Million)
Table 29 Germany bioanalytical testing services market, by test types, 2025 (USD Million)
Table 30 Germany ADME services market, by type, 2025 (USD Million)
Table 31 Asia Pacific bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 32 Asia Pacific large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 33 Asia Pacific large molecule immunoassay services market, by type, 2025 (USD Million)
Table 34 Asia Pacific bioanalytical testing services market, by test types, 2025 (USD Million)
Table 35 Asia Pacific ADME services market, by type, 2025 (USD Million)
Table 36 Japan bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 37 Japan large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 38 Japan large molecule immunoassay services market, by type, 2025 (USD Million)
Table 39 Japan bioanalytical testing services market, by test types, 2025 (USD Million)
Table 40 Japan ADME services market, by type, 2025 (USD Million)
Table 41 China bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 42 China large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 43 China large molecule immunoassay services market, by type, 2025 (USD Million)
Table 44 China bioanalytical testing services market, by test types, 2025 (USD Million)
Table 45 China ADME services market, by type, 2025 (USD Million)
Table 46 Latin America bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 47 Latin America large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 48 Latin America large molecule immunoassay services market, by type, 2025 (USD Million)
Table 49 Latin America bioanalytical testing services market, by test types, 2025 (USD Million)
Table 50 Latin America ADME services market, by type, 2025 (USD Million)
Table 51 Brazil bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 52 Brazil large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 53 Brazil large molecule immunoassay services market, by type, 2025 (USD Million)
Table 54 Brazil bioanalytical testing services market, by test types, 2025 (USD Million)
Table 55 Brazil ADME services market, by type, 2025 (USD Million)
Table 56 Mexico bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 57 Mexico large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 58 Mexico large molecule immunoassay services market, by type, 2025 (USD Million)
Table 59 Mexico bioanalytical testing services market, by test types, 2025 (USD Million)
Table 60 Mexico ADME services market, by type, 2025 (USD Million)
Table 61 MEA bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 62 MEA large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 63 MEA large molecule immunoassay services market, by type, 2025 (USD Million)
Table 64 MEA bioanalytical testing services market, by test types, 2025 (USD Million)
Table 65 MEA ADME services market, by type, 2025 (USD Million)
Table 66 South Africa bioanalytical testing services market, by molecule type, 2014 - 2025 (USD Million)
Table 67 South Africa large molecule bioanalytical testing services market, by type, 2025 (USD Million)
Table 68 South Africa large molecule immunoassay services market, by type, 2025 (USD Million)
Table 69 South Africa bioanalytical testing services market, by test types, 2025 (USD Million)
Table 70 South Africa ADME services market, by type, 2025 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market summary (USD Million), 2016
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Global pharmaceutical R&D spending, 2008 - 2022 (USD Billion)
Figure 12 Market restraint relevance analysis (Current & future impact)
Figure 13 Penetration & growth prospect mapping
Figure 14 SWOT Analysis, By Factor (political & legal, economic and technological)
Figure 15 Porter’s Five Forces Analysis
Figure 16 Company Market Share Analysis, 2016(Percent)
Figure 17 Bioanalytical testing services market, molecule type outlook key takeaways
Figure 18 Bioanalytical testing services market: Molecule type movement analysis
Figure 19 Small molecule bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 20 Large molecule bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 21 Large molecule LC-MS studies market, 2014 - 2025 (USD Million)
Figure 22 Immunoassay services market, 2014 - 2025 (USD Million)
Figure 23 Immunoassay PK services market, 2014 - 2025 (USD Million)
Figure 24 ADA services market, 2014 - 2025 (USD Million)
Figure 25 Other large molecule immunoassay tests market, 2014 - 2025 (USD Million)
Figure 26 Other large molecule tests market, 2014 - 2025 (USD Million)
Figure 27 Bioanalytical testing services market, test type outlook key takeaways
Figure 28 Bioanalytical testing services market: Molecule type movement analysis
Figure 29 ADME testing services market, 2014 - 2025 (USD Million)
Figure 30 In-vivo ADME testing services market, 2014 - 2025 (USD Million)
Figure 31 In-vitro ADME testing services market, 2014 - 2025 (USD Million)
Figure 32 PK testing services market, 2014 - 2025 (USD Million)
Figure 33 PD testing services market, 2014 - 2025 (USD Million)
Figure 34 Bioavailability testing services market, 2014 - 2025 (USD Million)
Figure 35 Bioequivalence testing services market, 2014 - 2025 (USD Million)
Figure 36 Other tests services market, 2014 - 2025 (USD Million)
Figure 37 Regional market place: Key takeaways
Figure 38 Regional outlook, 2016 & 2025
Figure 39 North America bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 40 U.S. Bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 41 Canada bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 42 Europe bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 43 UK bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 44 Germany bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 45 Asia Pacific bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 46 Japan bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 47 China bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 48 Latin America bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 49 Brazil bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 50 Mexico bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 51 MEA bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 52 South Africa bioanalytical testing services market, 2014 - 2025 (USD Million)
Figure 53 Strategy framework
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Pharmaceutical Product Development, LLC. (PPD)
  • ICON plc
  • Covance, Inc
  • Charles River Laboratories International, Inc.
  • Laboratory Corporation of America
  • inVentiv Health
  • SGS SA
  • Toxikon, Inc
  • Intertek Group plc
  • Pace Analytical Services, LLC
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll